Electric Scooter (FNS01,FNS03)
Anhui JBH Medical Apparatus Co., Ltd. · Decision date Sep 24, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 2026-09-24 for K261078, a traditional 510(k) submitted by Anhui Jbh Medical Apparatus Co., Ltd. for the Electric Scooter (FNS01, FNS03). The device falls under product code INI, regulation 890.3800, with Physical Medicine as the regulation medical specialty and review panel. The application was received on 04/01/2026 and was not reviewed by a third party; it was not recorded as a combination product, and no predetermined change control plan was authorized.
SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The public record identifies the device as a motorized three-wheeled vehicle classification entry and lists two model designations, FNS01 and FNS03, but does not describe components, changed items, or the predicate comparison. The linked summary document was not part of the public information, so the basis for the equivalence finding and any device-specific performance data remain unknown.
The record also does not state indications for use, patient-selection criteria, or marketing limitations. Readers should treat the clearance date and applicant details as the confirmed facts and consult the FDA summary for the technical and clinical basis of the decision.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Sep 24, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261078
- Regulatory pathway
- 510(k) premarket notification
- Product code
- INI
- Decision code
- SESE
- Decision date
- Sep 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Vehicle, Motorized 3-Wheeled.
- Product code
- INI
- FDA device class
- 2
FDA decision timeline
K261078 received
Application receipt date recorded by FDA.
K261078 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code INI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Nanjing Mijo Technology Co., Ltd. | 510(k) clearance | Sep 29, 2026 | FDA | |
| Zhejiang Kailang Technology Co., Ltd. | 510(k) clearance | Sep 29, 2026 | FDA | |
| Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Sep 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Anhui JBH Medical Apparatus Co., Ltd.
- Headquarters
- Not reported
- Brand website
- jbhmedical.com
- FDA applicant address
- Chuzhou
Sources and methodology
- Original FDA record: K261078
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

